Journal of Cancer Metastasis and Treatment
All Journals
Search Log In
Home Articles Special Issues Volumes Webinars Videos
Journal of Cancer Metastasis and Treatment
Search Submit
Home Articles Special Issues Volumes Webinars Videos

fig6

From:  ImmuneScore as a novel RNA-based prognostic signature superior to PD-L1 in advanced non-squamous NSCLC patients receiving chemotherapy combined with immune checkpoint inhibitor therapy
ImmuneScore as a novel RNA-based prognostic signature superior to PD-L1 in advanced non-squamous NSCLC patients receiving chemotherapy combined with immune checkpoint inhibitor therapy

Figure 6. Significant KEGG signaling pathways involved in the high versus low ImmuneScore group. Several immune-associated pathways were enriched in the high ImmuneScore group, which were highlighted with yellow frame border.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)
Navigation
Follow Us
Navigation

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2024 OAE Publishing Inc., except certain content provided by third parties